Literature DB >> 26771791

Improved Outcomes in Critically Ill Patients With AIDS: How Does This Trend Continue?

Daniel A Sweeney1, Kevan Akrami, Atul Malhotra.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26771791      PMCID： PMC4847539          DOI： 10.1097/CCM.0000000000001492

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  14 in total

1.  Characteristics and Outcome of Patients With AIDS in Dutch ICUs Between 1997 and 2014.

Authors:  Michaëla A Huson; Ferishta Bakhshi-Raiez; Martin P Grobusch; Evert de Jonge; Nicolette F de Keizer; Tom van der Poll
Journal:  Crit Care Med       Date:  2016-02       Impact factor: 7.598

2.  A randomized trial of noninvasive positive end expiratory pressure in patients with acquired immune deficiency syndrome and hypoxemic respiratory failure.

Authors:  Carlos Frederico Dantas Anjos; Guilherme Paula Pinto Schettino; Marcelo Park; Vladimir Silva Souza; Augusto Scalabrini Neto
Journal:  Respir Care       Date:  2011-07-12       Impact factor: 2.258

Review 3.  Critical illness in HIV-infected patients in the era of combination antiretroviral therapy.

Authors:  Kathleen M Akgün; Laurence Huang; Alison Morris; Amy C Justice; Margaret Pisani; Kristina Crothers
Journal:  Proc Am Thorac Soc       Date:  2011-06

4.  Do-not-resuscitate status and observational comparative effectiveness research in patients with septic shock*.

Authors:  Mark A Bradford; Peter K Lindenauer; Renda Soylemez Wiener; Allan J Walkey
Journal:  Crit Care Med       Date:  2014-09       Impact factor: 7.598

5.  Noninvasive ventilation for treating acute respiratory failure in AIDS patients with Pneumocystis carinii pneumonia.

Authors:  Marco Confalonieri; Edo Calderini; Susanna Terraciano; Giovanna Chidini; Enza Celeste; Giacomo Puccio; Cesare Gregoretti; G Umberto Meduri
Journal:  Intensive Care Med       Date:  2002-07-06       Impact factor: 17.440

6.  Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit.

Authors:  Enrique Casalino; Michel Wolff; Philippe Ravaud; Christophe Choquet; Fabrice Bruneel; Bernard Regnier
Journal:  AIDS       Date:  2004-07-02       Impact factor: 4.177

7.  Characteristics and outcomes of HIV-infected patients in the ICU: impact of the highly active antiretroviral treatment era.

Authors:  Benoît Vincent; Jean-François Timsit; Marc Auburtin; Frédérique Schortgen; Lila Bouadma; Michel Wolff; Bernard Regnier
Journal:  Intensive Care Med       Date:  2004-02-06       Impact factor: 17.440

8.  Predictive ability of acute physiology and chronic health evaluation II scoring applied to human immunodeficiency virus-positive patients.

Authors:  M C Brown; W B Crede
Journal:  Crit Care Med       Date:  1995-05       Impact factor: 7.598

9.  Should highly active antiretroviral therapy be prescribed in critically ill HIV-infected patients during the ICU stay? A retrospective cohort study.

Authors:  Agnes Meybeck; Lydie Lecomte; Michel Valette; Nicolas Van Grunderbeeck; Nicolas Boussekey; Arnaud Chiche; Hugues Georges; Yazdan Yazdanpanah; Olivier Leroy
Journal:  AIDS Res Ther       Date:  2012-09-28       Impact factor: 2.250

10.  The ART of caring for patients with HIV infection in the ICU.

Authors:  Krista Powell; Laurence Huang
Journal:  Intensive Care Med       Date:  2009-07-28       Impact factor: 17.440
View more
  2 in total

1.  HIV treatment non-adherence is associated with ICU mortality in HIV-positive critically ill patients.

Authors:  Nelson Bf Neto; Luiz G Marin; Bruna G de Souza; Ana Ld Moro; Wagner L Nedel
Journal:  J Intensive Care Soc       Date:  2020-01-14

2.  Outcomes and factors influencing outcomes of critically ill HIV-positive patients in a tertiary care center in South India.

Authors:  I Ramya; Shubankar Mitra; Shilpa D'Sa; Sowmya Sathyendra; Anand Zachariah; C Vignesh Kumar; Ronald Albert Benton Carey; George M Verghese
Journal:  J Family Med Prim Care       Date:  2019-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.